{"count": 3, "results": [{"_id": "39505298", "pmid": 39505298, "title": "Simvastatin ameliorates adverse pregnancy by inhibiting glycolysis-related NETs in obstetrical antiphospholipid syndrome.", "journal": "Life Sci", "authors": ["Huo R", "Sun Q", "Lv Q", "Wang Y", "Qi W", "Zhang M", "Li L", "Wang X"], "date": "2024-11-04T00:00:00Z", "doi": "10.1016/j.lfs.2024.123215", "meta_date_publication": "2024 Nov 4", "meta_volume": "", "meta_issue": "", "meta_pages": "123215", "score": 50273.04, "text_hl": "@<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@Simvastatin@@@ ameliorates adverse pregnancy by inhibiting glycolysis-related NETs in obstetrical @<m>DISEASE_Antiphospholipid_Syndrome</m> @DISEASE_MESH:D016736 @@@antiphospholipid syndrome@@@.", "citations": {"NLM": "Huo R, Sun Q, Lv Q, Wang Y, Qi W, Zhang M, Li L, Wang X. Simvastatin ameliorates adverse pregnancy by inhibiting glycolysis-related NETs in obstetrical antiphospholipid syndrome. Life Sci. 2024 Nov 4;():123215. PMID: 39505298", "BibTeX": "@article{39505298, title={Simvastatin ameliorates adverse pregnancy by inhibiting glycolysis-related NETs in obstetrical antiphospholipid syndrome.}, author={Huo R and Sun Q and Lv Q and Wang Y and Qi W and Zhang M and Li L and Wang X}, journal={Life Sci}, pages={123215}}"}}, {"_id": "40939734", "pmid": 40939734, "title": "Simvastatin competitively inhibits cellular signalling of lipid-binding antiphospholipid antibodies.", "journal": "J Thromb Haemost", "authors": ["Marova D", "Frankenbach P", "Hollerbach A", "Strand S", "Ruf W", "Lackner KJ", "Müller-Calleja N"], "date": "2025-09-10T00:00:00Z", "doi": "10.1016/j.jtha.2025.08.027", "meta_date_publication": "2025 Sep 10", "meta_volume": "", "meta_issue": "", "meta_pages": "", "score": 50272.45, "text_hl": "@<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@Simvastatin@@@ competitively inhibits cellular signalling of @CHEMICAL_Lipids @CHEMICAL_MESH:D008055 @@@lipid@@@-binding @<m>DISEASE_Antiphospholipid_Syndrome</m> @DISEASE_MESH:D016736 @@@antiphospholipid antibodies@@@.", "citations": {"NLM": "Marova D, Frankenbach P, Hollerbach A, Strand S, Ruf W, Lackner KJ, Müller-Calleja N. Simvastatin competitively inhibits cellular signalling of lipid-binding antiphospholipid antibodies. J Thromb Haemost. 2025 Sep 10;():. PMID: 40939734", "BibTeX": "@article{40939734, title={Simvastatin competitively inhibits cellular signalling of lipid-binding antiphospholipid antibodies.}, author={Marova D and Frankenbach P and Hollerbach A and Strand S and Ruf W and Lackner KJ and Müller-Calleja N}, journal={J Thromb Haemost}}"}}, {"_id": "29699441", "pmid": 29699441, "title": "Simvastatin reduces antiphospholipid antibodies formation in patients with systemic lupus erythematosus: a preliminary study.", "journal": "Lupus", "authors": ["Kotyla PJ"], "date": "2018-08-01T00:00:00Z", "doi": "10.1177/0961203318772015", "meta_date_publication": "2018 Aug", "meta_volume": "27", "meta_issue": "9", "meta_pages": "1572-1573", "score": 50066.84, "text_hl": "@<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@Simvastatin@@@ reduces @<m>DISEASE_Antiphospholipid_Syndrome</m> @DISEASE_MESH:D016736 @@@antiphospholipid antibodies@@@ formation in @SPECIES_9606 @@@patients@@@ with @DISEASE_Lupus_Erythematosus_Systemic @DISEASE_MESH:D008180 @@@systemic lupus erythematosus@@@: a preliminary study.", "citations": {"NLM": "Kotyla PJ. Simvastatin reduces antiphospholipid antibodies formation in patients with systemic lupus erythematosus: a preliminary study. Lupus. 2018 Aug;27(9):1572-1573. PMID: 29699441", "BibTeX": "@article{29699441, title={Simvastatin reduces antiphospholipid antibodies formation in patients with systemic lupus erythematosus: a preliminary study.}, author={Kotyla PJ}, journal={Lupus}, volume={27}, number={9}, pages={1572-1573}}"}}]}